Fig. 1: Flow diagram of the participants.
From: Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men

Nab, neutralizing antibody.
From: Safety and immunogenicity of a tetravalent and bivalent SARS-CoV-2 protein booster vaccine in men

Nab, neutralizing antibody.